Otros idiomas Tenaya Therapeutics, Inc.

Acciones

TNYA

US87990A1060

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
3,1 ^USD	+5,44 %		-0,64 %	-4,32 %

27/06	Tenaya Therapeutics, Inc. Anuncia Actualizaciones en el Liderazgo de Investigación	CI
10/06	TENAYA THERAPEUTICS, INC. : William Blair & Co. reitera su recomendación de compra	ZM

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Tenaya Therapeutics Announces Research Leadership Updates	27/06
Tenaya Therapeutics, Inc. Announces Research Leadership Updates	27/06
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit	18/06
Tenaya Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	14/05
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting	02/05
North American Morning Briefing : Stock Futures -2-	19/03
Tenaya Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	18/03
Tenaya Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	18/03
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine	18/03
Tenaya Therapeutics, Inc. Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine	18/03
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences	27/02
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications	26/02
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications	26/02
Tenaya Therapeutics Insider Bought Shares Worth $9,999,999, According to a Recent SEC Filing	14/02
Tenaya Therapeutics Announces Pricing of Underwritten Offering	08/02
Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference	03/01
Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference	21/11
Tenaya Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Tenaya Therapeutics, Inc.

Acciones

TNYA

US87990A1060

Otros idiomas

Filtros